» Articles » PMID: 39531485

Evolutionary History of Calcium-sensing Receptors Unveils Hyper/hypocalcemia-causing Mutations

Overview
Specialty Biology
Date 2024 Nov 12
PMID 39531485
Authors
Affiliations
Soon will be listed here.
Abstract

Despite advancements in understanding the structure and functions of the Calcium Sensing Receptor (CaSR), gaps persist in our knowledge of the specific functions of its residues. In this study, we used phylogeny-based techniques to identify functionally equivalent orthologs of CaSR, predict residue significance, and compute specificity-determining position (SDP) scores to understand its evolutionary basis. The analysis revealed exceptional conservation of the CaSR subfamily, emphasizing the critical role of residues with high SDP scores in receptor activation and pathogenicity. To further enhance the findings, gradient-boosting trees were applied to differentiate between gain- and loss-of-function mutations responsible for hypocalcemia and hypercalcemia. Lastly, we investigated the importance of these mutations in the context of receptor activation dynamics. In summary, through comprehensive exploration of the evolutionary history of the CaSR subfamily, coupled with innovative phylogenetic methodologies, we identified activating and inactivating residues, providing valuable insights into the regulation of calcium homeostasis and its connections to associated disorders.

References
1.
Hao Y, Lei Z, Shi N, Yu L, Ji W, Zhang X . Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in . Front Endocrinol (Lausanne). 2022; 12:743517. PMC: 8795859. DOI: 10.3389/fendo.2021.743517. View

2.
Chun L, Zhang W, Liu J . Structure and ligand recognition of class C GPCRs. Acta Pharmacol Sin. 2012; 33(3):312-23. PMC: 4077135. DOI: 10.1038/aps.2011.186. View

3.
Brown D, Krishnamurthy N, Dale J, Christopher W, Sjolander K . Subfamily hmms in functional genomics. Pac Symp Biocomput. 2005; :322-33. View

4.
Gorvin C . Molecular and clinical insights from studies of calcium-sensing receptor mutations. J Mol Endocrinol. 2019; 63(2):R1-R16. DOI: 10.1530/JME-19-0104. View

5.
Dharmaraj P, Gorvin C, Soni A, Nelhans N, Olesen M, Boon H . Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1). J Clin Endocrinol Metab. 2020; 105(5). PMC: 7096312. DOI: 10.1210/clinem/dgaa111. View